CCR4 and cancer: Our findings revealed a novel role for FOXP3 in the regulation of CCR4 expression in tumor-infiltrating Tregs (Figure 7) and gave a molecular insight as to how immunosuppressive Tregs infiltrate into the TME, allowing us to disrupt the pathway implicated and increase cancer immunity.